Back

Estimating prevalence and characteristics of statin intolerance among high and very high cardiovascular risk patients in Germany between 2017-2020

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Digital health innovation: from artificial intelligence to clinical decision support m-Health & Mobile Apps ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Klaus G Parhofer

Ludwig Maximilians University, Munich (Germany)

5 More presentations in this session

Presentation thumbnail
Automated electronic health record frailty assessment for older cardiac patients
Doctor A. Anand (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Multi-category classification of left ventricle ejection fraction using a convolutional neural network
Professor R. Carter (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
Smartphone-based remote monitoring in chronic heart failure: patient & clinician user experience, impact on patient engagement and quality of life.
Miss A. Auton (London, GB)
Abstract Slides Video
Presentation thumbnail
Evaluation of cardiac function and 30-day clinical outcome with synchronized analysis of phonocardiogram and electrocardiogram in patients with acute myocardial infarction
Doctor W. Zhang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Deep learning-based electrocardiogram analysis detecting paroxysmal atrial fibrillation during sinus rhythm in patients with cryptogenic stroke : validation study using implantable cardiac monitoring
Assistant Professor K. Jeon (Seongnam, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Digital health innovation: from artificial intelligence to clinical decision support

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Quality of life and clusters of patient characteristics in individuals with statin intolerance
thumbnail
Congress Presentation
Statin adherence in primary care among patients with hypertension with and without other cardiometabolic diseases
thumbnail
Congress Presentation
Real-world prescribing patterns for lipid-lowering therapy in high cardiovascular risk patients in germany: a cross-sectional analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources